Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?
Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 4
Abstract
Liver biopsy is still useful in selected clinical situations in which it is the only tool to obtain information necessary for the diagnosis, the prognosis, and the decision for treatment. Main examples are viral hepatitis with confounding co-morbidities, non alcoholic fatty liver disease, and autoimmune liver diseases.
Authors and Affiliations
Dominique Larrey, Lucy Meunier, José Ursic-Bedoya
Keywords
Related Articles
- EP ID EP189413
- DOI 10.5604/01.3001.0010.0272
- Views 81
- Downloads 0
Evaluation of liver diseases in Iranian patients with primary antibody deficiencies
Introduction. Patients with primary antibody deficiency (PAD) can complicate with liver disease. This study was performed in order to study the prevalence and causes of hepatobiliary diseases in Iranian patients with PAD...
Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation
Amanita phalloides is the most relevant mushroom intoxication leading to acute liver failure. The two principal groups of toxins, the amatoxins and the phallotoxins, are small oligopeptides highly resistant to chemical...
Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
Background. Conflicting data have been reported on the prevalence of liver steatosis, its risk factors and its relationship with fibrosis in patients with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-inf...
Cigarette smoking and fatty liver
Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis
Background. Currently, there is no standardized treatment regimen for non-alcoholic steatohepatitis. Aim. We performed a metaanalysis of high quality randomized controlled trials that evaluated treatment response to metf...